BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 10228608)

  • 1. Inhibitory effect of andrographolide from Andrographis paniculata on PAF-induced platelet aggregation.
    Amroyan E; Gabrielian E; Panossian A; Wikman G; Wagner H
    Phytomedicine; 1999 Mar; 6(1):27-31. PubMed ID: 10228608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of Andrographis paniculata extract and its active diterpenoids on platelet aggregation.
    Thisoda P; Rangkadilok N; Pholphana N; Worasuttayangkurn L; Ruchirawat S; Satayavivad J
    Eur J Pharmacol; 2006 Dec; 553(1-3):39-45. PubMed ID: 17081514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by glaucocalyxin A of aggregation of rabbit platelets induced by ADP, arachidonic acid and platelet-activating factor, and inhibition of [3H]-PAF binding.
    Bin Z; Kun L
    Thromb Haemost; 1992 Apr; 67(4):458-60. PubMed ID: 1631795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of the Korean herbal medicine, Dae-Jo-Whan, on platelet-activating factor-induced platelet aggregation.
    Chang GT; Kang SK; Kim JH; Chung KH; Chang YC; Kim CH
    J Ethnopharmacol; 2005 Dec; 102(3):430-9. PubMed ID: 16125889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of specific antagonists on PAF-induced platelet aggregation and release of plasminogen activator.
    Hofmann B; Ostermann G; Hoffmann A; Klöcking HP; Kertscher HP
    Biomed Biochim Acta; 1988; 47(10-11):S157-60. PubMed ID: 3248103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibitory effect of TBN on platelet aggregation in rabbit].
    Xu CL; Shan LC; Sun YW; Wang YQ
    Zhong Yao Cai; 2010 Sep; 33(9):1450-3. PubMed ID: 21243778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prehispanolone, a novel platelet activating factor receptor antagonist from Leonurus heterophyllus.
    Lee CM; Jiang LM; Shang HS; Hon PM; He Y; Wong HN
    Br J Pharmacol; 1991 Jul; 103(3):1719-24. PubMed ID: 1657264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAF-induced platelet aggregation ex vivo as a method for monitoring pharmacological activity in healthy volunteers.
    Adamus WS; Heuer H; Meade CJ
    Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):415-20. PubMed ID: 2747341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological and pharmacological effects of pinusolide, a novel platelet activating factor antagonist.
    Yang HO; Kang YH; Suh DY; Kim YC; Han BH
    Planta Med; 1995 Dec; 61(6):519-22. PubMed ID: 8824945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo effects of SR 27417, a novel PAF antagonist, on rabbit platelet aggregation and [3H]-PAF binding.
    Herbert JM; Laplace MC; Maffrand JP
    J Lipid Mediat; 1992 Feb; 5(1):1-12. PubMed ID: 1327264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of glaucocalyxin A on aggregation and cAMP levels of rabbit platelets in vitro.
    Zhang B; Long K
    Zhongguo Yao Li Xue Bao; 1993 Jul; 14(4):347-50. PubMed ID: 8249632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
    Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activity of amide derivatives of ginkgolide A.
    Hu LH; Chen ZL; Xie YY
    J Asian Nat Prod Res; 2001; 3(3):219-27. PubMed ID: 11491398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of ketotifen on rabbit platelet aggregation and platelet activating factor formation from rat neutrophils].
    Wang XD; Bian RL
    Zhongguo Yao Li Xue Bao; 1990 Nov; 11(6):524-7. PubMed ID: 2130617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 14-deoxyandrographolide as a platelet activating factor antagonist in bovine neutrophils.
    Burgos RA; Hidalgo MA; Monsalve J; LaBranche TP; Eyre P; Hancke JL
    Planta Med; 2005 Jul; 71(7):604-8. PubMed ID: 16041644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation.
    Saeed SA; Rasheed H
    Acta Pharmacol Sin; 2003 Jan; 24(1):31-6. PubMed ID: 12511226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736.
    Crowley HJ; Yaremko B; Selig WM; Janero DR; Burghardt C; Welton AF; O'Donnell M
    J Pharmacol Exp Ther; 1991 Oct; 259(1):78-85. PubMed ID: 1656030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-platelet activating factor property of Rubia cordifolia Linn.
    Tripathi YB; Pandey S; Shukla SD
    Indian J Exp Biol; 1993 Jun; 31(6):533-5. PubMed ID: 8406601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of new PAF antagonists on PAF-induced rabbit platelet aggregation in vitro and ex vivo.
    Yue TL; Rabinovici R; Farhat M; Feuerstein G
    J Lipid Mediat; 1991; 3(1):13-26. PubMed ID: 1768837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modulating effects of adenosine on the process of human platelet activation].
    Prokudin VIu; Melkova OM; Karaulov AV; Porodenko NV
    Biull Eksp Biol Med; 1992 Jun; 113(6):606-8. PubMed ID: 1446028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.